194 related articles for article (PubMed ID: 37250921)
61. Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells.
He C; Wang C; Liu H; Shan B
BMC Cancer; 2022 Jul; 22(1):724. PubMed ID: 35778693
[TBL] [Abstract][Full Text] [Related]
62. Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.
Saleem A; Natkunam Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098335
[No Abstract] [Full Text] [Related]
63. Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.
Küçük C; Hu X; Gong Q; Jiang B; Cornish A; Gaulard P; McKeithan T; Chan WC
Am J Pathol; 2016 Jun; 186(6):1435-41. PubMed ID: 27060228
[TBL] [Abstract][Full Text] [Related]
64. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
65. Predicting treatment response of patients with extranodal natural killer/T-cell lymphoma based on levels of PD-L1 mRNA and soluble PD-L1.
Feng Y; Jing C; Yu X; Cao X; Xu C
Hematol Oncol; 2020 Oct; 38(4):467-477. PubMed ID: 32515093
[TBL] [Abstract][Full Text] [Related]
66. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus.
Nagata H; Konno A; Kimura N; Zhang Y; Kimura M; Demachi A; Sekine T; Yamamoto K; Shimizu N
Blood; 2001 Feb; 97(3):708-13. PubMed ID: 11157488
[TBL] [Abstract][Full Text] [Related]
67. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
[TBL] [Abstract][Full Text] [Related]
68. Molecular underpinning of extranodal NK/T-cell lymphoma.
Huang Y; de Leval L; Gaulard P
Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
[TBL] [Abstract][Full Text] [Related]
69. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
[TBL] [Abstract][Full Text] [Related]
70. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
[TBL] [Abstract][Full Text] [Related]
71. TP73-AS1 promotes malignant progression of NK/T cell lymphoma by regulating DKK1 methylation.
Zhang H; Huang Q
J BUON; 2021; 26(4):1530-1535. PubMed ID: 34565015
[TBL] [Abstract][Full Text] [Related]
72. The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations.
de Mel S; Li JB; Abid MB; Tang T; Tay HM; Ting WC; Poon LM; Chung TH; Mow B; Tso A; Ong KH; Chng WJ; Liu TC
Cytometry B Clin Cytom; 2018 Jan; 94(1):159-168. PubMed ID: 28431200
[TBL] [Abstract][Full Text] [Related]
73. An extraordinary T/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature.
Jiang Q; Liu S; Peng J; Xiong H; Xiong Z; Yang Y; Tan X; Gao X
Diagn Pathol; 2013 Jun; 8():94. PubMed ID: 23773344
[TBL] [Abstract][Full Text] [Related]
74. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
75. Primary central nervous system extranodal NK/T-cell lymphoma, nasal type: case report and review of the literature.
Guan H; Huang Y; Wen W; Xu M; Zan Q; Zhang Z
J Neurooncol; 2011 Jun; 103(2):387-91. PubMed ID: 20845062
[TBL] [Abstract][Full Text] [Related]
76. The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
Gao Y; Feng X; Song W; Li H; Shi C; Jin M; Li Z; Zhang L; Zhang M
Hematol Oncol; 2022 Oct; 40(4):678-688. PubMed ID: 35439335
[TBL] [Abstract][Full Text] [Related]
77. T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
de Mel S; Mustafa N; Selvarajan V; Azaman MI; Jaynes PW; Venguidessane S; Phuong HM; Alnaseri ZT; Phyu T; Girard LP; Chng WJ; Wardyn J; Li Y; An O; Yang H; Ng SB; Jeyasekharan AD
PLoS One; 2022; 17(1):e0261469. PubMed ID: 35077445
[TBL] [Abstract][Full Text] [Related]
78. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
[TBL] [Abstract][Full Text] [Related]
79. An Unusual Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Masquerading as Dacryocystitis and Sinusitis.
Eze AN; Kalejaiye AO
Ear Nose Throat J; 2023 Mar; 102(3):NP114-NP118. PubMed ID: 33559497
[TBL] [Abstract][Full Text] [Related]
80. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
